ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

Clinical Trials Renew By NCI Gets Under Way

May 3, 1985

FDA Approves NDA for Sodium Fluoride F18

February 4, 2011

In Brief: Jay Moskowitz Reassigned; Healy To Run For Ohio Republican Nomination To Senate

September 17, 1993

ODAC Recommends Approval Of Nplate For Thrombocytopenia.

March 21, 2008

NCI’s Supercomputer Undergoing Testing

April 11, 1986

ASCO President David Johnson to oncologists: It’s time to “reconnect to our patients” and “recommit to our profession.” Horning outlines priorities.

May 20, 2005